Alpha-antitrypsin Deficiency Treatment Market Report

Global and Region Alpha-antitrypsin Deficiency Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：143
  • REPORT CODE：GMM956480
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Alpha-antitrypsin Deficiency Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Alpha-antitrypsin Deficiency Treatmentmarket, defines the market attractiveness level of Alpha-antitrypsin Deficiency Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Alpha-antitrypsin Deficiency Treatment industry, describes the types of Alpha-antitrypsin Deficiency Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Alpha-antitrypsin Deficiency Treatment market and the development prospects and opportunities of Alpha-antitrypsin Deficiency Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Alpha-antitrypsin Deficiency Treatment market in Chapter 13.

    By Player:

    • Dicerna Pharmaceuticals, Inc

    • Inhibrx

    • Cevec Pharmaceuticals GmbH

    • Grifols, SA

    • rEVO Biologics, Inc

    • Carolus Therapeutics, Inc

    • Adverum Biotechnologies, Inc

    • Sangamo BioSciences, Inc

    • International Stem Cell Corporation

    • Editas Medicine, Inc

    • Intellia Therapeutics, Inc

    • Applied Genetic Technologies Corporation

    • Arrowhead Pharmaceuticals, Inc

    • Digna Biotech, SL

    • ProMetic Life Sciences Inc

    • Alnylam Pharmaceuticals, Inc

    • Kamada Ltd

    • Polyphor Ltd

    • Ionis Pharmaceuticals, Inc

    By Type:

    • CT-2009

    • POL-6014

    • ARO-AAT

    • ALNAAT-02

    • Others

    By End-User:

    • Clinic

    • Hospital

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Alpha-antitrypsin Deficiency Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Alpha-antitrypsin Deficiency Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Alpha-antitrypsin Deficiency Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Alpha-antitrypsin Deficiency Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Alpha-antitrypsin Deficiency Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Alpha-antitrypsin Deficiency Treatment Consumption (2017-2022)

    • 7.2 United States Alpha-antitrypsin Deficiency Treatment Consumption (2017-2022)

    • 7.3 Europe Alpha-antitrypsin Deficiency Treatment Consumption (2017-2022)

    • 7.4 China Alpha-antitrypsin Deficiency Treatment Consumption (2017-2022)

    • 7.5 Japan Alpha-antitrypsin Deficiency Treatment Consumption (2017-2022)

    • 7.6 India Alpha-antitrypsin Deficiency Treatment Consumption (2017-2022)

    • 7.7 South Korea Alpha-antitrypsin Deficiency Treatment Consumption (2017-2022)

    8 Region and Country-wise Alpha-antitrypsin Deficiency Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Alpha-antitrypsin Deficiency Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Alpha-antitrypsin Deficiency Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Alpha-antitrypsin Deficiency Treatment Consumption Forecast (2022-2028)

    • 8.4 China Alpha-antitrypsin Deficiency Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Alpha-antitrypsin Deficiency Treatment Consumption Forecast (2022-2028)

    • 8.6 India Alpha-antitrypsin Deficiency Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Alpha-antitrypsin Deficiency Treatment Consumption Forecast (2022-2028)

    9 Global Alpha-antitrypsin Deficiency Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Alpha-antitrypsin Deficiency Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global CT-2009 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global POL-6014 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global ARO-AAT Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global ALNAAT-02 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Alpha-antitrypsin Deficiency Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Alpha-antitrypsin Deficiency Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Alpha-antitrypsin Deficiency Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global CT-2009 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global POL-6014 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global ARO-AAT Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global ALNAAT-02 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Alpha-antitrypsin Deficiency Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Alpha-antitrypsin Deficiency Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Alpha-antitrypsin Deficiency Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Alpha-antitrypsin Deficiency Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Alpha-antitrypsin Deficiency Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Alpha-antitrypsin Deficiency Treatment Market Competitive Analysis

    • 14.1 Dicerna Pharmaceuticals, Inc

      • 14.1.1 Dicerna Pharmaceuticals, Inc Company Details

      • 14.1.2 Dicerna Pharmaceuticals, Inc Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Dicerna Pharmaceuticals, Inc Alpha-antitrypsin Deficiency Treatment Product and Service

    • 14.2 Inhibrx

      • 14.2.1 Inhibrx Company Details

      • 14.2.2 Inhibrx Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Inhibrx Alpha-antitrypsin Deficiency Treatment Product and Service

    • 14.3 Cevec Pharmaceuticals GmbH

      • 14.3.1 Cevec Pharmaceuticals GmbH Company Details

      • 14.3.2 Cevec Pharmaceuticals GmbH Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Cevec Pharmaceuticals GmbH Alpha-antitrypsin Deficiency Treatment Product and Service

    • 14.4 Grifols, SA

      • 14.4.1 Grifols, SA Company Details

      • 14.4.2 Grifols, SA Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Grifols, SA Alpha-antitrypsin Deficiency Treatment Product and Service

    • 14.5 rEVO Biologics, Inc

      • 14.5.1 rEVO Biologics, Inc Company Details

      • 14.5.2 rEVO Biologics, Inc Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 rEVO Biologics, Inc Alpha-antitrypsin Deficiency Treatment Product and Service

    • 14.6 Carolus Therapeutics, Inc

      • 14.6.1 Carolus Therapeutics, Inc Company Details

      • 14.6.2 Carolus Therapeutics, Inc Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Carolus Therapeutics, Inc Alpha-antitrypsin Deficiency Treatment Product and Service

    • 14.7 Adverum Biotechnologies, Inc

      • 14.7.1 Adverum Biotechnologies, Inc Company Details

      • 14.7.2 Adverum Biotechnologies, Inc Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Adverum Biotechnologies, Inc Alpha-antitrypsin Deficiency Treatment Product and Service

    • 14.8 Sangamo BioSciences, Inc

      • 14.8.1 Sangamo BioSciences, Inc Company Details

      • 14.8.2 Sangamo BioSciences, Inc Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Sangamo BioSciences, Inc Alpha-antitrypsin Deficiency Treatment Product and Service

    • 14.9 International Stem Cell Corporation

      • 14.9.1 International Stem Cell Corporation Company Details

      • 14.9.2 International Stem Cell Corporation Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 International Stem Cell Corporation Alpha-antitrypsin Deficiency Treatment Product and Service

    • 14.10 Editas Medicine, Inc

      • 14.10.1 Editas Medicine, Inc Company Details

      • 14.10.2 Editas Medicine, Inc Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Editas Medicine, Inc Alpha-antitrypsin Deficiency Treatment Product and Service

    • 14.11 Intellia Therapeutics, Inc

      • 14.11.1 Intellia Therapeutics, Inc Company Details

      • 14.11.2 Intellia Therapeutics, Inc Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Intellia Therapeutics, Inc Alpha-antitrypsin Deficiency Treatment Product and Service

    • 14.12 Applied Genetic Technologies Corporation

      • 14.12.1 Applied Genetic Technologies Corporation Company Details

      • 14.12.2 Applied Genetic Technologies Corporation Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Applied Genetic Technologies Corporation Alpha-antitrypsin Deficiency Treatment Product and Service

    • 14.13 Arrowhead Pharmaceuticals, Inc

      • 14.13.1 Arrowhead Pharmaceuticals, Inc Company Details

      • 14.13.2 Arrowhead Pharmaceuticals, Inc Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Arrowhead Pharmaceuticals, Inc Alpha-antitrypsin Deficiency Treatment Product and Service

    • 14.14 Digna Biotech, SL

      • 14.14.1 Digna Biotech, SL Company Details

      • 14.14.2 Digna Biotech, SL Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Digna Biotech, SL Alpha-antitrypsin Deficiency Treatment Product and Service

    • 14.15 ProMetic Life Sciences Inc

      • 14.15.1 ProMetic Life Sciences Inc Company Details

      • 14.15.2 ProMetic Life Sciences Inc Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 ProMetic Life Sciences Inc Alpha-antitrypsin Deficiency Treatment Product and Service

    • 14.16 Alnylam Pharmaceuticals, Inc

      • 14.16.1 Alnylam Pharmaceuticals, Inc Company Details

      • 14.16.2 Alnylam Pharmaceuticals, Inc Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Alnylam Pharmaceuticals, Inc Alpha-antitrypsin Deficiency Treatment Product and Service

    • 14.17 Kamada Ltd

      • 14.17.1 Kamada Ltd Company Details

      • 14.17.2 Kamada Ltd Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Kamada Ltd Alpha-antitrypsin Deficiency Treatment Product and Service

    • 14.18 Polyphor Ltd

      • 14.18.1 Polyphor Ltd Company Details

      • 14.18.2 Polyphor Ltd Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Polyphor Ltd Alpha-antitrypsin Deficiency Treatment Product and Service

    • 14.19 Ionis Pharmaceuticals, Inc

      • 14.19.1 Ionis Pharmaceuticals, Inc Company Details

      • 14.19.2 Ionis Pharmaceuticals, Inc Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Ionis Pharmaceuticals, Inc Alpha-antitrypsin Deficiency Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Alpha-antitrypsin Deficiency Treatment

    • Figure Alpha-antitrypsin Deficiency Treatment Picture

    • Table Global Alpha-antitrypsin Deficiency Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Alpha-antitrypsin Deficiency Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Alpha-antitrypsin Deficiency Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Alpha-antitrypsin Deficiency Treatment Consumption by Country (2017-2022)

    • Figure United States Alpha-antitrypsin Deficiency Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Alpha-antitrypsin Deficiency Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Alpha-antitrypsin Deficiency Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Alpha-antitrypsin Deficiency Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Alpha-antitrypsin Deficiency Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Alpha-antitrypsin Deficiency Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Alpha-antitrypsin Deficiency Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Alpha-antitrypsin Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Alpha-antitrypsin Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Alpha-antitrypsin Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Alpha-antitrypsin Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Alpha-antitrypsin Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Alpha-antitrypsin Deficiency Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CT-2009 Consumption and Growth Rate (2017-2022)

    • Figure Global POL-6014 Consumption and Growth Rate (2017-2022)

    • Figure Global ARO-AAT Consumption and Growth Rate (2017-2022)

    • Figure Global ALNAAT-02 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global CT-2009 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global POL-6014 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ARO-AAT Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ALNAAT-02 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Alpha-antitrypsin Deficiency Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Alpha-antitrypsin Deficiency Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Dicerna Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Dicerna Pharmaceuticals, Inc Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dicerna Pharmaceuticals, Inc Alpha-antitrypsin Deficiency Treatment Product and Service

    • Table Inhibrx (Foundation Year, Company Profile and etc.)

    • Table Inhibrx Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Inhibrx Alpha-antitrypsin Deficiency Treatment Product and Service

    • Table Cevec Pharmaceuticals GmbH (Foundation Year, Company Profile and etc.)

    • Table Cevec Pharmaceuticals GmbH Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cevec Pharmaceuticals GmbH Alpha-antitrypsin Deficiency Treatment Product and Service

    • Table Grifols, SA (Foundation Year, Company Profile and etc.)

    • Table Grifols, SA Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Grifols, SA Alpha-antitrypsin Deficiency Treatment Product and Service

    • Table rEVO Biologics, Inc (Foundation Year, Company Profile and etc.)

    • Table rEVO Biologics, Inc Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table rEVO Biologics, Inc Alpha-antitrypsin Deficiency Treatment Product and Service

    • Table Carolus Therapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table Carolus Therapeutics, Inc Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Carolus Therapeutics, Inc Alpha-antitrypsin Deficiency Treatment Product and Service

    • Table Adverum Biotechnologies, Inc (Foundation Year, Company Profile and etc.)

    • Table Adverum Biotechnologies, Inc Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Adverum Biotechnologies, Inc Alpha-antitrypsin Deficiency Treatment Product and Service

    • Table Sangamo BioSciences, Inc (Foundation Year, Company Profile and etc.)

    • Table Sangamo BioSciences, Inc Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sangamo BioSciences, Inc Alpha-antitrypsin Deficiency Treatment Product and Service

    • Table International Stem Cell Corporation (Foundation Year, Company Profile and etc.)

    • Table International Stem Cell Corporation Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table International Stem Cell Corporation Alpha-antitrypsin Deficiency Treatment Product and Service

    • Table Editas Medicine, Inc (Foundation Year, Company Profile and etc.)

    • Table Editas Medicine, Inc Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Editas Medicine, Inc Alpha-antitrypsin Deficiency Treatment Product and Service

    • Table Intellia Therapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table Intellia Therapeutics, Inc Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Intellia Therapeutics, Inc Alpha-antitrypsin Deficiency Treatment Product and Service

    • Table Applied Genetic Technologies Corporation (Foundation Year, Company Profile and etc.)

    • Table Applied Genetic Technologies Corporation Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Applied Genetic Technologies Corporation Alpha-antitrypsin Deficiency Treatment Product and Service

    • Table Arrowhead Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Arrowhead Pharmaceuticals, Inc Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arrowhead Pharmaceuticals, Inc Alpha-antitrypsin Deficiency Treatment Product and Service

    • Table Digna Biotech, SL (Foundation Year, Company Profile and etc.)

    • Table Digna Biotech, SL Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Digna Biotech, SL Alpha-antitrypsin Deficiency Treatment Product and Service

    • Table ProMetic Life Sciences Inc (Foundation Year, Company Profile and etc.)

    • Table ProMetic Life Sciences Inc Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table ProMetic Life Sciences Inc Alpha-antitrypsin Deficiency Treatment Product and Service

    • Table Alnylam Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Alnylam Pharmaceuticals, Inc Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alnylam Pharmaceuticals, Inc Alpha-antitrypsin Deficiency Treatment Product and Service

    • Table Kamada Ltd (Foundation Year, Company Profile and etc.)

    • Table Kamada Ltd Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kamada Ltd Alpha-antitrypsin Deficiency Treatment Product and Service

    • Table Polyphor Ltd (Foundation Year, Company Profile and etc.)

    • Table Polyphor Ltd Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Polyphor Ltd Alpha-antitrypsin Deficiency Treatment Product and Service

    • Table Ionis Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Ionis Pharmaceuticals, Inc Alpha-antitrypsin Deficiency Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ionis Pharmaceuticals, Inc Alpha-antitrypsin Deficiency Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US